Replies to post #194110 on Amarin Corp Plc (AMRN)

[retinadoc]

Thanks Sam. IMHO Evaporate is a huge potential catalyst that the Street has essentially ignored. Patient's can easily visualize the concept of a 'liquid stent" (think Drano for your coronary arteries). The data is purely objective and irrefutable. I agree that every CV patient that is a potential candidate for surgical intervention (stent or bypass) or has historically undergone these procedures will be put on Vascepa based on this study. Cherry was done with a much lower dose and its results were still very robust.